Frequently asked questions

Is neuroAD Therapy System right for me?

The neuroAD Therapy System offers treatment for mild to moderate Alzheimer’s Disease. A specific assessment will be carried out by you physician to evaluate if the neuroAD treatment is suitable for you. Currently, the neuroAD Therapy System is commercially available and CE-marked in Europe. The system is not cleared by US-FDA, and as such currently not commercially available in the USA. You and your physician should discuss the potential benefits in your specific case.

Can I take my regular medications?

neuroAD Therpay System treatments are not contraindicated for use in conjunction with any existing drug therapies and you are encouraged to continue taking any medications prescribed by your physician.

Is neuroAD Therapy safe?

The neuroAD Therapy System has been thoroughly tested and there have been no serious adverse events reported.

Where have the trial results been published?

Results have been published in peer-reviewed journals and presented at international scientific conferences. You can review them here.

Is neuroAD Therapy System available today?

neuroAD Therapy System is commercially available in Europe and Israel. The system is not cleared by US-FDA, and as such currently not commercially available in the USA.

Check here to see if neuroAD is commercially available in your area.

Who is behind the ongoing research and development?

Neuronix’s team of engineers, neuropsychologists, researchers and physicians developed this unique and breakthrough technology. In addition, the development team is supported by the company’s Scientific consultin panel, which includes several world-leading researchers in Neurology and Alzheimer’s Disease.

 


neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.



® January 12, 2017 Neuronix | All rights reserved.